Gannex Announces Positive Clinical Results in Overweight and Obese Subjects for Its THR-b Agonist ASC41
Gannex (Shanghai, China) has announced positive clinical results in overweigth and obse subjects for its THR-b agonist ASC41.
For detail information, see the Gannex's press release.
https://www.ascletis.com/news_detail/175/id/462.html